51 related articles for article (PubMed ID: 2576469)
21. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
[TBL] [Abstract][Full Text] [Related]
22. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
Ozata M; Oktenli C; Bingol N; Ozdemir IC
Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
Schernthaner G; Matthews DR; Charbonnel B; Hanefeld M; Brunetti P;
J Clin Endocrinol Metab; 2004 Dec; 89(12):6068-76. PubMed ID: 15579760
[TBL] [Abstract][Full Text] [Related]
24. A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes.
Barrington P; Chien JY; Showalter HD; Schneck K; Cui S; Tibaldi F; Ellis B; Hardy TA
Diabetes Obes Metab; 2011 May; 13(5):426-33. PubMed ID: 21251178
[TBL] [Abstract][Full Text] [Related]
25. Effect of CCK-8 on basal and meal-stimulated somatostatin in the baboon.
Figlewicz DP; Woods SC; Porte D; Taborsky GJ
Peptides; 1986; 7(5):771-4. PubMed ID: 2879277
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
[TBL] [Abstract][Full Text] [Related]
27. Plasma somatostatin 28 increases in response to feeding in man.
Polonsky KS; Shoelson SE; Docherty HM
J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
[TBL] [Abstract][Full Text] [Related]
28. Plasma somatostatin increases during hypoglycaemia in insulin-dependent patients with and without B-cell function.
Madsbad S; Hilsted J; Krarup T; Tronier B; Sestoft L
Clin Endocrinol (Oxf); 1983 Jul; 19(1):47-51. PubMed ID: 6137295
[TBL] [Abstract][Full Text] [Related]
29. Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals.
McCreight LJ; Mari A; Coppin L; Jackson N; Umpleby AM; Pearson ER
Diabetologia; 2020 Feb; 63(2):444-447. PubMed ID: 31758212
[No Abstract] [Full Text] [Related]
30. Plasma somatostatin response to an oral test meal in liver transplant patients.
Barreca T; Franceschini R; Pellicci R; Carozzi S; Bruno E; Dardano G; Rolandi E; Valente U
Metabolism; 1997 Sep; 46(9):1003-7. PubMed ID: 9284887
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin response to a mixed meal in normals and in type I diabetics.
Uccioli L; Ghirlanda G; Cotroneo P; Bianchini G; Manto A; Solini A; Annese V; Greco AV
Peptides; 1986; 7 Suppl 1():287-91. PubMed ID: 2875450
[TBL] [Abstract][Full Text] [Related]
32. The effect of glucose on the plasma concentration of somatostatin during caloric deficiency in man.
Oktedalen O; Opstad PK; Holst JJ
Scand J Gastroenterol; 1993 Jul; 28(7):652-6. PubMed ID: 8103238
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin in diabetes.
Navarro MA; Morató J; Rosel P; Gómez JM
Clin Chem; 1983 Dec; 29(12):2118-9. PubMed ID: 6139185
[No Abstract] [Full Text] [Related]
34. [The treatment of diabetes mellitus with metformin].
de FOCKERT J
Ned Tijdschr Geneeskd; 1963 Jun; 107():1130-4. PubMed ID: 13945675
[No Abstract] [Full Text] [Related]
35. [USE OF PROLONGED FASTING IN THE TREATMENT OF OBESITY].
CATELLIER RC
Laval Med; 1963 Sep; 34():821-2. PubMed ID: 14052075
[No Abstract] [Full Text] [Related]
36. [Not Available].
Müssig K
MMW Fortschr Med; 2021 Oct; 163(17):28-29. PubMed ID: 34595630
[No Abstract] [Full Text] [Related]
37. [Somatostatin-like activity (SLI) in the blood during metformin treatment of obese patients with diabetes mellitus type 2].
Lawecki J; Stryjek-Kamińska D; Schusdziarra V
Pol Arch Med Wewn; 1989 Mar; 81(3):183-8. PubMed ID: 2576469
[TBL] [Abstract][Full Text] [Related]
38. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
40. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics.
Miyazaki K; Funakoshi A; Ibayashi H
Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
